Trial Profile
Evaluation of the Efficacy and Safety of Single, Daily Oral Doses of SYN-010 Compared to Placebo in Adult Patients With Irritable Bowel Syndrome With Constipation (EASE-DO)
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 27 Mar 2023
Price :
$35
*
At a glance
- Drugs Lovastatin (Primary)
- Indications Irritable bowel syndrome
- Focus Registrational; Therapeutic Use
- 01 Dec 2022 Results from NCT03763175 and NCT04557215; evaluating distinct gut microtypes linked to breath gas patterns in IBS-C and IBS-D subjects, published in the American Journal of Gastroenterology
- 27 Oct 2021 Results of post-hoc analysis evaluating correlation between exhaled CH4 levels and heart rate and vagal tone, presented at the American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course 2021
- 23 May 2021 Results (n=53) assessing cytokine profile associated with change in exhaled methane over a 14-week time period ; serum and stool samples were collected at two different timepoints from subjects with IBS-C and IMO presented at the Digestive Disease Week 2021